Pacer Advisors »

Travere Therapeutics shares owned by Pacer Advisors

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 2.8k 7.71
2021-03-31 $57k 2.3k 24.86
2020-12-31 $42k 1.5k 27.11

More positions owned by Pacer Advisors

Exxon Mobil Corp Common Stock - Domestic (XOM)
3M Common Stock - Domestic (MMM)
Valero Energy Corp Common Stock - Domestic (VLO)
Vistra Corp Common Stock - Domestic (VST)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Marathon Petroleum Corp Common Stock - Domestic (MPC)
Chevron Corp Common Stock - Domestic (CVX)
Altria Group Common Stock - Domestic (MO)
EOG Resources Common Stock - Domestic (EOG)
CVS Health Corp Common Stock - Domestic (CVS)
At&t Common Stock - Domestic (T)
United States Treasury Bill Treasury Bill (Principal)
Cisco Systems Common Stock - Domestic (CSCO)
Gilead Sciences Common Stock - Domestic (GILD)
Diamondback Energy Common Stock - Domestic (FANG)

View all positions for Pacer Advisors

Top funds holding Travere Therapeutics

BlackRock
Armistice Capital
Deep Track Capital
State Street Corporation
Vanguard Group
Macquarie Group
Morgan Stanley
Rock Springs Capital Management
Renaissance Technologies
Deutsche Bank Aktiengesellschaft
Pictet Asset Management Holding SA
Millennium Management
Kynam Capital Management
D. E. Shaw & Co
Emerald Advisers

View all funds holding Travere Therapeutics